The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication seems to offer impressive improvements in fat reduction compared to previous therapies. Early research studies have indicat